|
|
|
|
| LEADER |
02427nmm a2200313 u 4500 |
| 001 |
EB002073306 |
| 003 |
EBX01000000000000001213396 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
220928 ||| eng |
| 020 |
|
|
|a 9789264769465
|
| 020 |
|
|
|a 9789264606975
|
| 020 |
|
|
|a 9789264477896
|
| 245 |
0 |
0 |
|a Trade in Counterfeit Pharmaceutical Products
|h Elektronische Ressource
|c Organisation for Economic Co-operation and Development and European Union Intellectual Property Office
|
| 260 |
|
|
|a Paris
|b OECD Publishing
|c 2020
|
| 300 |
|
|
|a 94 p.
|c 21 x 28cm
|
| 505 |
0 |
|
|a Introduction -- Executive Summary -- Preface -- The push factors behind counterfeit pharmaceuticals -- Impact of counterfeit medicines -- Counterfeit pharmaceuticals: scope and data -- Acronyms and abbreviations -- The supply chain: marketing, transport and distribution -- Foreword -- Additional Tables -- Concluding remarks -- Mapping the scale of the fake pharmaceutical challenge -- Efforts to combat counterfeit pharmaceuticals -- Industry overview -- Data and methodology
|
| 653 |
|
|
|a Governance
|
| 653 |
|
|
|a Trade
|
| 710 |
2 |
|
|a Organisation for Economic Co-operation and Development
|
| 710 |
2 |
|
|a European Union Intellectual Property Office
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b OECD
|a OECD Books and Papers
|
| 490 |
0 |
|
|a Illicit Trade
|
| 028 |
5 |
0 |
|a 10.1787/a7c7e054-en
|
| 856 |
4 |
0 |
|a oecd-ilibrary.org
|u https://doi.org/10.1787/a7c7e054-en
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 320
|
| 082 |
0 |
|
|a 380
|
| 520 |
|
|
|a This report, one in a series of studies by the OECD and the European Union Intellectual Property Office (EUIPO), enhances understanding of the issues and challenges facing governments, businesses and society posed by the trade in fake pharmaceutical products. Illicit markets for fake pharmaceuticals are attractive for counterfeiters, given the high profit margins, low risks of detection and prosecution, weak penalties, and the ease with which consumers can be deceived into believing that the counterfeit products are genuine. Counterfeit medicines not only cause economic damage for the sector, but are also a significant threat to public health, since fake medicines are often not properly formulated and may contain dangerous ingredients. Fake pharmaceuticals include antibiotics, lifestyle treatments, pain killers, anti-malarial drugs, diabetes treatments and central nervous system medicines
|